Trial
NCT02929394
Trabectedin Maintenance Post 1st-line in STS
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
PharmaMar
Condition
Sarcoma, Soft Tissue
Intervention
Trabectedin
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-02